Evonik
Mario Gomez-Andreu currently serves as the Head of Strategic Innovation in the Health Care business line at Evonik, where responsibilities include identifying and implementing relevant technologies and business concepts in the healthcare space. With a history at Evonik dating back to February 2001, Mario has held multiple roles, including Vice President of Innovation Networks and Communications, where a focus on Cross-Industry Innovation and partnership development was emphasized. Previous positions also encompassed Director of Global New Business Development for Acrylic Monomers and New Business Development Manager for Europe, highlighting skills in identifying growth opportunities and formulating business strategies. Earlier career experience includes serving as Associate Lecturer at Universidad Central de Las Villas. Mario holds a Postdoctoral Fellowship in Homogeneous Catalysis from Leibniz-Institut für Organische Katalyse Rostock, a PhD in Organic Chemistry from Universität Rostock, and a Licentiate degree in Chemistry from Universidad Central de Las Villas.
This person is not in the org chart
Evonik
12 followers
Evonik is a Germany-based specialty chemicals company that operates in four segments: The Nutrition and Care segment produces specialty chemicals, mainly for use in consumer goods for daily needs and food, as well as nutrition for animal food and healthcare products; the Resource Efficiency segment offers material solutions for environment-friendly and energy-efficient products used in the automotive, adhesives and construction industries, among others; the Performance Materials segment produces polymer materials and their intermediates, mainly for the rubber, plastics and agriculture sectors, and the Services segment comprises site management, utilities and waste management, as well as technical, process technology, engineering and logistics services for the chemicals segments and external customers at the Company's sites. Its majority shareholder is RAG Stiftung.